Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 May;71(5):1457–1466. doi: 10.1172/JCI110899

Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region.

H O Gloor, F Urthaler, T N James
PMCID: PMC437010  PMID: 6853721

Abstract

Amiodarone was selectively perfused into the sinus node artery and atrioventricular node artery of 51 dogs. Amiodarone had an immediate negative chronotropic and dromotropic effect. Threshold concentration was 2.5 micrograms/ml. 25 and 50 micrograms/ml of amiodarone injected into the sinus node artery slowed the heart by 25.6 +/- 3.1 and 33.7 +/- 2.6 beats/min (mean +/- 1 SEM), respectively. Amiodarone 25 and 50 micrograms/ml injected into the AV node artery during AV junctional rhythm slowed the AV junctional pacemaker by 12.2 +/- 1.8 and 17.4 +/- 1.7 beats/min, respectively. Injections of amiodarone into the AV node artery during sinus rhythm regularly increased AV conduction time sometimes causing 2 degrees AV block at the highest concentration used. Impaired conduction was exclusively measured at the level of the A-H interval in the His electrogram. Neither atropine nor propranolol prevented the negative chronotropic effects of amiodarone. Amiodarone had no significant effect on sinus node response to either stellate stimulation or intranodal administration of norepinephrine. The negative chronotropic action of amiodarone was significantly enhanced when amiodarone was administered in a perfusate containing low (0.6 mM) instead of normal calcium. Taken collectively these observations indicate that amiodarone has immediate depressant electrophysiologic effects on both the sinus node and the AV junction and that these early effects might involve the blockade of the slow channel.

Full text

PDF
1457

Images in this article

1459Image
on p.1459
1461Image
on p.1461
1462Image
on p.1462
1462Image
on p.1462
1463Image
on p.1463
1464Image
on p.1464

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong C. M. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J Gen Physiol. 1971 Oct;58(4):413–437. doi: 10.1085/jgp.58.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacq Z. M., Blakeley A. G., Summers R. J. The effects of amiodarone, an alpha and beta receptor antiagonist, on adrenergic transmission in the cat spleen. Biochem Pharmacol. 1976 May 15;25(10):1195–1199. doi: 10.1016/0006-2952(76)90368-3. [DOI] [PubMed] [Google Scholar]
  3. Benaim R., Denizeau J. P., Melon J., Domengie B., Kolsky H., Chapelle M., Chiche P. Les effets antiarythmiques de l'amiodarone injectable. A propos de 100 cas. Arch Mal Coeur Vaiss. 1976 May;69(5):513–522. [PubMed] [Google Scholar]
  4. Boucher M., Duchene-Marullaz D. Comparative effects of amiodarone, perhexiline and bepridil on the cardiac rhythms of the unanesthetized dog in chronic heart block. Arch Int Pharmacodyn Ther. 1978 May;233(1):65–75. [PubMed] [Google Scholar]
  5. Brown H. F., Giles W., Noble S. J. Membrane currents underlying activity in frog sinus venosus. J Physiol. 1977 Oct;271(3):783–816. doi: 10.1113/jphysiol.1977.sp012026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown H. F., Noble S. J. Proceedings: Effects of adrenaline on membrane currents underlying pacemaker activity in frog atrial muscle. J Physiol. 1974 Apr;238(1):51P–53P. [PubMed] [Google Scholar]
  7. Cabasson J., Puech P., Mellet J. M., Guimond C., Bachy C., Sassine A. Analyse des effets électrophysiologiques de l'amiodarone par l'enregistrement simultané des potentiels d'action monophasiques et du faisceau de His. Arch Mal Coeur Vaiss. 1976 Jul;69(7):691–699. [PubMed] [Google Scholar]
  8. Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol. 1970 Aug;39(4):668–674. doi: 10.1111/j.1476-5381.1970.tb09892.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Charlier R., Deltour G., Baudine A., Chaillet F. Pharmacology of amiodarone, and anti-anginal drug with a new biological profile. Arzneimittelforschung. 1968 Nov;18(11):1408–1417. [PubMed] [Google Scholar]
  10. Coumel P., Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980 Dec;100(6 Pt 2):1063–1069. doi: 10.1016/0002-8703(80)90214-8. [DOI] [PubMed] [Google Scholar]
  11. Coutte R., Fontaine G., Frank R., Dragodanne C., Phan-Thuc H., Facquet J. Etude électrocardiologique des effets de l'amiodarone sur la conduction intracardiaque chez l'homme. Comparaison entre les voies intraveineuse et orale. Ann Cardiol Angeiol (Paris) 1976 Dec;25(6):543–548. [PubMed] [Google Scholar]
  12. Côté P., Bourassa M. G., Delaye J., Janin A., Froment R., David P. Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation. 1979 Jun;59(6):1165–1172. doi: 10.1161/01.cir.59.6.1165. [DOI] [PubMed] [Google Scholar]
  13. Goupil N., Lenfant J. The effects of amiodarone on the sinus node activity of the rabbit heart. Eur J Pharmacol. 1976 Sep;39(1):23–31. doi: 10.1016/0014-2999(76)90109-6. [DOI] [PubMed] [Google Scholar]
  14. Heger J. J., Prystowsky E. N., Jackman W. M., Naccarelli G. V., Warfel K. A., Rinkenberger R. L., Zipes D. P. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med. 1981 Sep 3;305(10):539–545. doi: 10.1056/NEJM198109033051002. [DOI] [PubMed] [Google Scholar]
  15. Hille B. The selective inhibition of delayed potassium currents in nerve by tetraethylammonium ion. J Gen Physiol. 1967 May;50(5):1287–1302. doi: 10.1085/jgp.50.5.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. JAMES T. N., NADEAU R. A. Direct perfusion of the sinus node: an experimental model for pharmacologic and electrophysiologic studies of the heart. Henry Ford Hosp Med Bull. 1962 Mar;10:21–25. [PubMed] [Google Scholar]
  17. James T. N., Bear E. S., Frink R. J., Lang K. F., Tomlinson J. C. Selective stimulation, suppression, or blockade of the atrioventricular node and His bundle. J Lab Clin Med. 1970 Aug;76(2):240–256. [PubMed] [Google Scholar]
  18. Kaski J. C., Girotti L. A., Messuti H., Rutitzky B., Rosenbaum M. B. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation. 1981 Aug;64(2):273–279. doi: 10.1161/01.cir.64.2.273. [DOI] [PubMed] [Google Scholar]
  19. Kenyon J. L., Gibbons W. R. Influence of chloride, potassium, and tetraethylammonium on the early outward current of sheep cardiac Purkinje fibers. J Gen Physiol. 1979 Feb;73(2):117–138. doi: 10.1085/jgp.73.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lubbe W. F., McFadyen M. L., Muller C. A., Worthington M., Opie L. H. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol. 1979 Mar;43(3):533–540. doi: 10.1016/0002-9149(79)90010-9. [DOI] [PubMed] [Google Scholar]
  21. Lupi G. A., Urthaler F., James T. N. Effects of verapamil on automaticity and conduction with particular reference to tachyphylaxis. Eur J Cardiol. 1979 May;9(5):345–368. [PubMed] [Google Scholar]
  22. Marcus F. I., Fontaine G. H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J. 1981 Apr;101(4):480–493. doi: 10.1016/0002-8703(81)90140-x. [DOI] [PubMed] [Google Scholar]
  23. Olsson S. B., Brorson L., Varnauskas E. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J. 1973 Dec;35(12):1255–1259. doi: 10.1136/hrt.35.12.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Polster P., Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976 Jan 15;25(2):131–134. doi: 10.1016/0006-2952(76)90279-3. [DOI] [PubMed] [Google Scholar]
  25. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  26. Sicart M., Besse P., Choussat A., Bricaud H. Action hémodynamique de l'amiodarone intra-veineuse chez l'homme. Arch Mal Coeur Vaiss. 1977 Mar;70(3):219–227. [PubMed] [Google Scholar]
  27. Singh B. N., Jewitt D. E., Downey J. M., Kirk E. S., Sonnenblick E. H. Effects of amiodarone and L8040, novel antianginal and antiarrhythmic drugs, on cardiac and coronary haemodynamics and on cardiac intracellular potentials. Clin Exp Pharmacol Physiol. 1976 Sep-Oct;3(5):427–442. doi: 10.1111/j.1440-1681.1976.tb00620.x. [DOI] [PubMed] [Google Scholar]
  28. Singh B. N., Vaughan Williams E. M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657–667. doi: 10.1111/j.1476-5381.1970.tb09891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Touboul P., Atallah G., Gressard A., Kirkorian G. Effects of amiodarone on sinus node in man. Br Heart J. 1979 Nov;42(5):573–578. doi: 10.1136/hrt.42.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Touboul P., Huerta F., Porte J., Delahaye J. P. Bases électrophysiologiques de l'action antiarythmique de l'amiodarone chez l'homme. Arch Mal Coeur Vaiss. 1976 Aug;69(8):845–853. [PubMed] [Google Scholar]
  31. Tsien R. W. Effects of epinephrine on the pacemaker potassium current of cardiac Purkinje fibers. J Gen Physiol. 1974 Sep;64(3):293–319. doi: 10.1085/jgp.64.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Urthaler F., James T. N. A comparison of His bundle electrograms recorded from the aortic root and from a plaque sutured near the His bundle. J Lab Clin Med. 1975 May;85(5):711–722. [PubMed] [Google Scholar]
  33. Urthaler F., James T. N. Experimental studies on the pathogenesis of asystole after verapamil in the dog. Am J Cardiol. 1979 Oct;44(4):651–656. doi: 10.1016/0002-9149(79)90283-2. [DOI] [PubMed] [Google Scholar]
  34. Vancrombreucq J. C., Sergysels R. Utilisation de l'amiodarone injectable chez des patients insuffisants respiratoires chroniques. Arch Mal Coeur Vaiss. 1980 Feb;73(2):205–210. [PubMed] [Google Scholar]
  35. Vaughan Williams E. M. QT and action potential duration. Br Heart J. 1982 Jun;47(6):513–514. doi: 10.1136/hrt.47.6.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Vic-Dupont V., Vachon F., Gibert C., Trémolières F., Manuel C., Goursot G. Traitment intensif du tétanos aigu généralisé de l'adulte. I. -La réanimation respiratoire. Nouv Presse Med. 1976 Jan 3;5(1):31–34. [PubMed] [Google Scholar]
  37. Waleffe A., Bruninx P., Kulbertus H. E. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. J Electrocardiol. 1978 Jul;11(3):253–260. doi: 10.1016/s0022-0736(78)80125-3. [DOI] [PubMed] [Google Scholar]
  38. Wellens H. J., Lie K. I., Bär F. W., Wesdorp J. C., Dohmen H. J., Düren D. R., Durrer D. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1976 Aug;38(2):189–194. doi: 10.1016/0002-9149(76)90148-x. [DOI] [PubMed] [Google Scholar]
  39. Woods W. T., Urthaler F., James T. N. Effects of tetraethylammonium and 4-aminopyridine upon canine sinus node. J Mol Cell Cardiol. 1981 Oct;13(10):889–901. doi: 10.1016/0022-2828(81)90288-1. [DOI] [PubMed] [Google Scholar]
  40. Zipes D. P., Troup P. J. New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am J Cardiol. 1978 May 22;41(6):1005–1024. doi: 10.1016/0002-9149(78)90853-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES